middl
east
respiratori
syndrom
coronaviru
emerg
viru
may
lead
sever
acut
respiratori
ill
frequent
associ
multiorgan
failur
death
object
chapter
summar
current
state
knowledg
regard
pathogenesi
clinic
manifest
diagnosi
manag
outcom
infect
focus
critic
ill
viru
first
isol
patient
fatal
pneumonia
acut
kidney
injuri
jeddah
saudi
arabia
june
identif
viru
link
cluster
respiratori
ill
jordan
date
back
march
diseas
epidemiolog
character
sporad
case
throughout
year
surg
case
occur
hospit
outbreak
decemb
world
health
organ
report
case
includ
least
relat
death
case
occur
countri
case
link
resid
travel
arabian
peninsula
major
case
occur
saudi
arabia
south
korea
saudi
arabia
multipl
hospit
outbreak
occur
alahsa
jeddah
april
may
riyadh
outbreak
republ
korea
start
may
result
case
travel
histori
middl
east
saudi
arabia
qatar
unit
arab
emir
bahrain
subsequ
transmiss
occur
close
contact
famili
member
patient
share
room
ward
infect
patient
healthcar
worker
care
infect
patient
led
case
infect
last
case
korea
juli
coronavirus
famili
envelop
rna
virus
infect
anim
human
propens
cross
speci
caus
varieti
ill
rang
common
cold
sever
respiratori
ill
sever
acut
respiratori
syndrom
coronaviru
first
coronaviru
identifi
caus
widespread
outbreak
critic
ill
caus
worldwid
outbreak
winter
eventu
lead
confirm
case
includ
death
sar
epidem
contain
belong
lineag
b
betacoronaviru
wherea
belong
lineag
c
genu
enter
cell
via
common
receptor
dipeptidyl
also
known
replic
bronchial
bronchiolar
type
ii
alveolar
epitheli
cell
viru
primarili
detect
respiratori
secret
highest
viral
load
lower
respiratori
tract
case
one
studi
show
approxim
patient
continu
respiratori
shed
day
infect
often
manifest
acut
kidney
injuri
aki
pathogenesi
remain
unknown
although
direct
viral
infect
possibl
sinc
receptor
heavili
express
human
kidney
viral
shed
also
detect
urin
stool
infect
patient
accumul
evid
camel
primari
sourc
transmiss
viru
isol
dromedari
camel
high
viral
load
upper
respiratori
tract
infect
camel
suggest
transmiss
human
occur
close
camel
contact
transmiss
ingest
camel
product
meat
milk
possibl
never
confirm
serosurveil
studi
individu
saudi
arabia
posit
serolog
document
seroposit
common
men
women
central
coastal
provinc
shepherd
slaughterhous
worker
other
may
explain
least
part
sporad
case
seen
low
rate
throughout
year
transmiss
demonstr
among
close
household
contact
famili
member
howev
sustain
transmiss
report
secondari
transmiss
within
healthcar
set
describ
patient
healthcar
worker
acquir
diseas
attribut
overcrowd
movement
infect
patient
yet
diagnosi
breach
infect
prevent
control
practic
studi
evalu
stabil
differ
environment
condit
found
viru
stabl
low
temperaturelow
humid
higher
temperatur
higher
humid
condit
could
recov
h
rel
humid
condit
aerosol
decreas
stabil
observ
rel
humid
condit
prolong
environment
presenc
suggest
may
transmit
via
contact
fomit
although
confirm
diseas
spectrum
rang
asymptomat
infect
rapidli
progress
sever
respiratori
failur
multiorgan
failur
symptomat
case
manifest
incub
period
day
sever
case
report
adult
chronic
comorbid
includ
diabet
mellitu
chronic
cardiac
diseas
chronic
lung
diseas
kidney
diseas
immunosuppress
howev
sever
infect
may
also
occur
among
younger
patient
includ
healthcar
worker
compar
affect
older
patient
men
women
peopl
comorbid
ill
infect
occur
within
first
week
index
case
ill
sar
occur
mainli
second
week
like
due
differ
time
peak
viral
load
current
literatur
suggest
children
rare
affect
common
clinic
featur
critic
ill
patient
fever
cough
dyspnea
gastrointestin
symptom
common
laboratori
abnorm
includ
leukopenia
lymphocytopenia
thrombocytopenia
elev
serum
creatinin
lactat
dehydrogenas
alter
liver
enzym
initi
chest
radiograph
abnorm
symptomat
patient
find
rang
minim
abnorm
extens
bilater
infiltr
figur
show
chest
radiograph
four
patient
pneumonia
first
day
intub
demonstr
differ
pattern
lung
infiltr
comput
tomographi
ct
find
includ
bilater
airspac
opac
predominantli
subpleur
basilar
lung
region
extens
opac
consolid
rapid
progress
hypoxem
respiratori
failur
requir
intub
usual
occur
within
first
week
symptom
onset
one
observ
studi
singl
center
saudi
arabia
octob
may
sever
infect
requir
icu
admiss
occur
case
requir
invas
mechan
ventil
univari
analysi
factor
associ
sever
infect
requir
icu
admiss
age
year
odd
ratio
confid
interv
ci
male
sex
ci
higher
charlson
comorbid
index
ci
presenc
bilater
pulmonari
infiltr
chest
radiograph
ci
concomit
infect
ci
serum
albumin
gl
diagnosi
ci
sever
neurolog
syndrom
includ
alter
level
conscious
rang
confus
coma
ataxia
focal
motor
deficit
report
three
critic
ill
patient
brain
magnet
reson
imag
mri
show
widespread
bilater
hyperintens
lesion
imag
white
matter
subcort
area
differ
brain
area
issu
guidanc
definit
case
base
clinic
criteria
exposur
histori
diagnost
find
shown
tabl
clinic
radiolog
manifest
differenti
infect
caus
respiratori
infect
diagnosi
therefor
base
molecular
test
polymeras
chain
reaction
two
site
viru
genom
upstream
e
protein
upe
screen
open
read
frame
orf
confirm
lower
respiratori
tract
specimen
higher
sensit
upper
respiratori
tract
specimen
detect
success
test
depend
experi
expertis
laboratori
personnel
avoid
contamin
type
specimen
condit
gene
sequenc
target
rdrp
present
corona
virus
n
specif
gene
fragment
use
confirm
also
diagnos
seroconvers
two
sampl
two
week
apart
immunosorb
assay
use
screen
immunofluoresc
assay
ifa
neutral
confirm
sever
serolog
assay
develop
need
valid
viru
cultur
commonli
avail
cell
line
howev
requir
special
biosafeti
level
laboratori
risk
transmiss
within
healthcar
set
appropri
patient
isol
strict
implement
infect
prevent
control
measur
crucial
manag
case
suspect
case
recommend
droplet
contact
precaut
perform
aerosol
gener
procedur
eg
aspir
open
suction
respiratori
tract
intub
bronchoscopi
cardiopulmonari
resuscit
airborn
precaut
addit
appli
center
diseas
control
prevent
cdc
recommend
droplet
precaut
ad
standard
precaut
provid
care
patient
symptom
acut
respiratori
infect
suspect
confirm
case
isol
airborn
infect
isol
room
construct
maintain
accord
current
guidelin
room
avail
patient
transfer
soon
feasibl
facil
one
avail
transfer
patient
wear
facemask
isol
room
door
close
healthcar
worker
adher
standard
contact
airborn
precaut
hand
hygien
perform
appropri
person
protect
equip
includ
respir
appli
correctli
addit
visit
restrict
control
hospit
also
develop
protocol
readi
potenti
increas
need
isol
patient
suspect
confirm
infect
earli
support
manag
includ
supplement
oxygen
hypoxemia
respiratori
distress
shock
earli
invas
mechan
ventil
signific
respiratori
distress
persist
hypoxemia
patient
acut
respiratori
distress
syndrom
ard
receiv
care
includ
ventil
strategi
target
tidal
volum
mlkg
predict
bodi
weight
plateau
airway
pressur
mmhg
moder
sever
ard
case
mmhg
candid
earli
prone
posit
earli
neuromuscular
blockad
h
prone
recommend
within
h
ard
onset
least
h
sinc
approach
associ
reduc
mortal
compar
manag
patient
supin
posit
infus
intraven
cisatracurium
within
h
ard
onset
also
associ
reduc
mortal
compar
placebo
extracorpor
membran
oxygen
ecmo
option
patient
refractori
hypoxemia
success
use
young
patient
sever
influenza
refractori
hypoxemia
well
patient
systemat
corticosteroid
gener
avoid
unless
indic
establish
reason
effect
corticosteroid
outcom
patient
unknown
howev
corticosteroid
use
associ
increas
morbid
patient
sever
influenza
oxygen
ventil
oscillatori
ventil
probabl
avoid
use
caution
mer
patient
potenti
gener
aerosol
lack
effect
patient
ard
systemat
review
found
follow
procedur
associ
increas
risk
acut
respiratori
infect
transmiss
healthcar
worker
endotrach
intub
ventil
tracheotomi
manual
ventil
strict
infect
prevent
practic
therefor
employ
intervent
perform
conserv
fluid
manag
advoc
especi
presenc
hypoxemia
absenc
shock
renal
replac
therapi
rrt
start
patient
aki
controversi
howev
presenc
fluid
overload
start
rrt
associ
wors
outcom
start
ultrafiltr
lower
degre
fluid
overload
earli
target
neg
balanc
may
benefici
earli
trophic
feed
day
ard
patient
permiss
underfeed
day
mechan
ventil
patient
shown
equival
target
feed
outcom
includ
surviv
underfeed
may
prefer
patient
prone
posit
date
effect
specif
treatment
infect
data
ribavirin
interferon
convalesc
plasma
limit
studi
rhesu
macaqu
found
combin
ribavirin
associ
reduct
replic
improv
outcom
clinic
studi
combin
ribavirin
interferon
show
inconsist
result
convalesc
sera
patient
recov
may
use
studi
sever
influenza
found
reduc
mortal
antibodi
treatment
compar
placebo
treatment
pool
ci
includ
studi
low
low
qualiti
three
studi
separ
laboratori
report
develop
fulli
human
neutral
monoclon
antibodi
clinic
data
current
avail
repurpos
drug
statin
mycophenol
acid
necrosi
factor
agent
potenti
antivir
effect
time
excel
safeti
record
may
treatment
option
howev
drug
recommend
clinic
use
outsid
clinic
trial
current
licens
vaccin
howev
work
ongo
develop
effect
vaccin
overal
case
fatal
rate
infect
howev
mortal
rate
patient
sever
ill
requir
critic
care
higher
requir
icu
admiss
hospit
patient
frequent
observ
studi
case
requir
icu
admiss
die
progress
diseas
cours
death
multivari
regress
analysi
presenc
concomit
infect
ci
low
serum
albumin
ci
associ
need
icu
admiss
multivari
analysi
show
age
year
independ
risk
factor
increas
mortal
ci
aki
hepat
dysfunct
cardiac
arrhythmia
tachyarrhythmia
sever
bradycardia
requir
temporari
pacemak
insert
common
complic
anoth
observ
studi
critic
ill
case
found
barotrauma
occur
vasopressor
need
rrt
perform
median
time
onset
symptom
intub
day
rang
day
median
icu
hospit
length
stay
day
day
respect
patient
tracheostomi
mortal
rate
respect
note
mortal
case
korean
outbreak
compar
saudi
arabia
sept
howev
composit
two
cohort
differ
rel
percentag
asymptomat
mildli
symptomat
case
korean
healthcar
author
appli
widespread
screen
intensifi
public
health
measur
contact
trace
quarantin
isol
suspect
case
contact
least
day
identif
asymptomat
mildli
symptomat
patient
differ
patient
characterist
comorbid
condit
may
led
overal
lower
mortal
rate
korea
three
year
identif
remain
major
global
threat
infect
frequent
sever
associ
signific
morbid
mortal
although
understand
viru
diseas
continu
evolv
larg
knowledg
gap
remain
arabian
peninsula
remain
affect
region
concern
spread
viru
countri
global
zoonot
transfer
viru
anim
human
stop
risk
addit
domest
perhap
intern
outbreak
persist
moreov
urgent
need
larger
epidemiolog
outcom
studi
random
control
trial
examin
differ
therapeut
intervent
collabor
intern
health
author
research
center
necessari
crucial
achiev
goal
